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Abstract. 
 
Two major isoforms of the cell adhesion mol-
ecule neurofascin NF186 and NF155 are expressed in 
the central nervous system (CNS). We have investi-
gated their roles in the assembly of the node of Ranvier 
and show that they are targeted to distinct domains at 
the node. At the onset of myelination, NF186 is re-
stricted to neurons, whereas NF155 localizes to oligo-
dendrocytes, the myelin-forming glia of the CNS. Coin-
cident with axon ensheathment, NF155 clusters at the 
paranodal regions of the myelin sheath where it local-
izes in apposition to the axonal adhesion molecule 
paranodin/contactin-associated protein (Caspr1), which 
is a constituent of the septate junction-like axo-glial ad-
hesion zone. Immunoelectron microscopy conﬁrmed 
that neurofascin is a glial component of the paranodal 
axo-glial junction. Concentration of NF155 with Caspr1 
at the paranodal junctions of peripheral nerves is also a 
feature of Schwann cells. In 
 
Shiverer
 
 mutant mice, 
which assemble neither compact CNS myelin nor nor-
mal paranodes, NF155 (though largely retained at the 
cell body) is also distributed at ectopic sites along ax-
ons, where it colocalizes with Caspr1. Hence, NF155 is 
the ﬁrst glial cell adhesion molecule to be identiﬁed in 
the paranodal axo-glial junction, where it likely inter-
acts with axonal proteins in close association with 
Caspr1.
Key words: glia • node of Ranvier • neurofascin • my-
elination • paranode
 
Introduction
 
The rapid rate of nerve impulse conduction, which is char-
acteristic of myelinated fibers in the central nervous sys-
tem (CNS),
 
1
 
 is dependent on the high density of sodium
channels at the node of Ranvier (Ritchie and Rogart,
1977). Therefore, clustering of these ion channels is a key
event in the morphological and functional maturation of
the vertebrate CNS. Oligodendrocytes, the myelin-form-
ing glia of the CNS, are believed to have an important role
in sodium channel clustering (Vabnick and Shrager, 1998).
One proposal is that oligodendrocytes exert their influ-
ence on neurons by means of a secreted factor (Kaplan
et al., 1997). More recent work has highlighted the signifi-
cance of axo-glial contact adjacent to the node as a prereq-
uisite for the assembly of a functional node (Rasband et al.,
1999). These paranodal axo-glial adhesive zones bear a
strong morphological similarity to the septate junctions
found in invertebrates (for review see Salzer, 1997).
In addition to their putative involvement in defining
the site of the node of Ranvier, paranodal axo-glial junc-
tions are also believed to function as a barrier to ion flow
in the mature nerve (Chiu and Ritchie, 1981). However,
in spite of their probable importance, the molecular basis
of axo-glial interaction at the paranodal junctions is still
poorly understood. Paranodin/Caspr1 (contactin-associ-
ated protein 1) is an axonal constituent of the axo-glial
adhesion zone and has been proposed to play an impor-
tant role in paranodal junction formation (Einheber et
al., 1997; Menegoz et al., 1997; Peles et al., 1997a,b). Sup-
port for this view has come from studies on the nerves of
 
Shiverer 
 
(
 
Shi
 
) mouse mutants and of mice deficient in the
enzyme UDP-galactose-ceramide galactosyltransferase
(CGT) in which Caspr1 fails to concentrate at the para-
nodes (Dupree et al., 1999; Rasband et al., 1999). How-
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ever, the glial counterparts of Caspr1 have yet to be iden-
tified.
Neurofascin is an ankyrin-binding, cell adhesion mole-
cule of the L1 subgroup of the immunoglobulin G super-
family that has been implicated in neurite outgrowth,
fasciculation, and interneuronal adhesion (Rathjen and
Schachner, 1984; Grumet et al., 1991; Volkmer and
Rathjen, 1992; Volkmer et al., 1992; Davis et al., 1993;
Zhang et al., 1998). The neurofascin gene is subject to ex-
tensive alternative splicing (Hassel et al., 1997), and two of
the best characterized products are a 186-kD isoform
(NF186), typical of myelinated axons, and found at nodes
of Ranvier and axonal initial segments, and a 155-kD iso-
form (NF155), which has been localized to unmyelinated
axons in the peripheral nervous system (PNS; Davis et al.,
1996). Compared with NF 186, NF155 contains an extra fi-
bronectin type III (FNIII) repeat and lacks a mucinlike
domain (Davis et al., 1996).
All functional studies of neurofascin have sought to elu-
cidate its role in neurons (Rathjen and Schachner, 1984;
Rathjen et al., 1987a,b; Brummendorf and Rathjen, 1996;
Brummendorf et al., 1998). However, there is some evi-
dence that neurofascin might be expressed in cells that
have been identified, on the basis of their morphology, as
oligodendrocytes (Moscoso and Sanes, 1995). We have
confirmed this observation and have suggested that the
specific isoform expressed in oligodendrocytes is NF155
(Collinson et al., 1998). Expression of neurofascin mRNA
is first detectable at the initiation of myelination, but once
the ensheathment of target axons begins in earnest, the
amount of neurofascin mRNA in oligodendrocytes de-
clines precipitously. This transient peak of expression at
the onset of myelination in the CNS suggested that neuro-
fascin might be a strong candidate to mediate and signal
axon–glial interaction. Here, we show that NF155 is tar-
geted to the paranodal loops of the sheath, where they in-
teract with Caspr1 on the axon. Hence, NF155 is the first
glial cell adhesion molecule of the paranodal junctional
complex to be described.
 
Materials and Methods
 
Antibodies, Immunoprecipitation, and Immunoblotting
 
Antibodies against neurofascin were generated in New Zealand white
rabbits against three peptides coupled to keyhole Limpet hemocyanin by
means of a terminal cysteine (Research Genetics). The first antibody
(NFC1) was raised against a region at the extreme COOH terminus of the
intracellular domain common to both NF186 and NF155 (CGNES-
SEATSPVNAAIYSLA), the second (NFF3) to the third FNIII domain
specific to NF155 (CLWVSQKRQQASFPGDRPR), and the third (MNF2)
to a sequence within the mucin domain specific to NF186 (CTESP-
TTTTGTKIHETAPDEQS). 
Each antibody was affinity-purified by immunoabsorption to a column
of peptide coupled to aminohexyl Sepharose 4B (Sigma Chemical Co.).
Other primary antibodies used were against myelin-associated glycopro-
tein (MAG; mouse mAb; Boehringer Mannheim), ankyrin
 
G
 
 (mouse mono-
clonal; Zymed Laboratories Inc.), phosphorylated neurofilament M
NFM (mouse monoclonal, RMO108; a gift of Dr. V.M.-Y. Lee, University
of Pennsylvania, Philadelphia, PA) contactin (rabbit antiserum, a gift
from Dr. J. Trotter, Department of Neurobiology, University of Heidel-
berg, Germany), and phosphotyrosine (mouse monoclonal MCPY; Up-
state Biotechnology). The cDNA of the entire Caspr1 cytoplasmic region
was used to generate rabbit and guinea pig antisera, as has been described
elsewhere (Menegoz et al., 1997; Peles et al., 1997b). In brief, the primers
that flank the cytoplasmic region were used in reverse transcriptase (RT)–
 
PCR of RNA from adult rat brain stem and cerebellum. The resulting
cDNA was cloned into pGEX4T2 (Amersham Pharmacia Biotech) and
verified by sequencing. The fusion protein expressed in 
 
Escherichia coli
 
(strain BL21; Stratagene) was purified on glutathione-Sepharose (Amer-
sham Pharmacia Biotech). 
Peroxidase-coupled antisera were purchased from the Scottish Anti-
body Production Unit. Antisera and affinity-purified antibodies (NFC1,
1:2,000; NFF3, 1:100; and MNF2, 1:100) were tested by Western blot anal-
ysis as described previously (Gillespie et al., 1994). For immunoprecipita-
tion, optic nerves or brains were removed from 10- and 12-d-old mice and
homogenized in 250 
 
m
 
l ice-cold lysis buffer (25 mM Hepes, 10 mM EDTA,
5 mM NaF, 15 mM Na
 
4
 
P
 
2
 
O
 
7
 
?
 
10 H
 
2
 
O, 1 mM benzamidine, 0.5 mM Na
 
3
 
VO
 
4
 
,
peptide inhibitors [P8340; Sigma Chemical Co.], and 1 mM PMSF, pH
7.4). The homogenate was solubilized for 5 min on ice by adding an equal
volume of 2% Triton X-100 in lysis buffer. After centrifugation at 4
 
8
 
C for
15 min at 13,000 
 
g
 
, NFC1 or Caspr1 antibody at a dilution of 1:100 coupled
to 5 mg of protein A agarose was added to the cleared supernatant and
tumbled for 2 h at 4
 
8
 
C. The immune complexes were harvested by centrif-
ugation and washed twice with lysis buffer and twice with 0.1% Triton
X-100 in lysis buffer. Proteins were solubilized, resolved on 8% SDS poly-
acrylamide gels, and transferred electrophoretically to Protran nitrocellu-
lose (Schleicher & Schuell) as previously described (Gillespie et al., 1994).
The membrane was blocked overnight in 5% milk solids and probed with
NFC1 (1:2,000), anti-Caspr1 (1:1,000), or anticontactin (1:1000) diluted in
PBS containing 0.2% gelatin, 0.1% Tween 20, pH 7.4; followed by goat
anti–rabbit IgG-HRP conjugate (1:1,000), or with MCPY diluted (1:1,000)
in 3% milk solids in PBS, followed by goat anti–mouse IgG-HRP conju-
gate (1:2,000). Conjugates were detected using the ECL system according
to the manufacturer’s instructions (Amersham International).
 
Cell Cultures
 
Dorsal root ganglion (DRG) cultures were prepared following the proce-
dure described by Bunge and co-workers (Kleitman et al., 1991). In brief,
12-mm glass coverslips, inserted into 4-well dishes (NUNC), were coated
at room temperature for 1 h with Matrigel (Collaborative Biomedical prod-
ucts) diluted 1:30 in L15 medium. Spinal cords were removed from E16
Sprague-Dawley rat embryos, and the attached DRGs were removed and
dissociated by trypsin treatment before plating on the matrigel-coated cov-
erslips. Dissociated DRG were plated in C media (MEM, 10% FCS, 0.4%
glucose, and 100 ng/ml NGF). After two cycles of antimitotic feeding (Kleit-
man et al., 1991), the cultures were reseeded with Schwann cells. Ascorbic
acid (50 
 
m
 
g/ml) was added to the medium to trigger myelination. Primary
Schwann cells were prepared from newborn rat sciatic nerves following
the method described by Brockes (Brockes et al., 1979). Schwann cells were
grown on poly-
 
L
 
-lysine–coated coverslips in DME containing 10% FCS.
 
Immunofluorescence Microscopy
 
CNS and PNS tissues were fixed by transcardial perfusion with 4%
paraformaldehyde in 0.1 M sodium phosphate, pH 7.4. After extensive
washing with 0.1 M sodium phosphate, pH 7.4, the tissue was cryopro-
tected by immersion for 15 min each in 5%, then 10% sucrose in 0.1 M
phosphate buffer, pH 7.4, and finally overnight in 25% sucrose in 0.1 M
phosphate buffer, pH 7.4, at 4
 
8
 
C. After embedding in OCT (Tissue TEK)
blocks were frozen in isopentane cooled in liquid nitrogen. Sections
(8–10 
 
m
 
m) were collected on 3-aminopropyltriethoxysilane subbed glass
slides, and OCT was removed by washing in PBS (Sigma Chemical Co.).
Sciatic nerve fibers were teased in 0.1% Triton X-100 in PBS. Before incu-
bation with the NFF3 antibody, sections or teased sciatic nerve fibers were
treated with Bouin’s reagent for 1 min. Samples were blocked for 3 h in
0.2% Triton X-100, 0.2% gelatin in PBS, pH 7.4, containing either 10%
nonimmune goat serum when using rabbit and mouse primary antibodies,
or donkey serum when the sheep antibody was used. The antibodies were
applied overnight in 4% nonimmune serum in the same buffer, and after
washing them in buffer without serum, fluorescently labeled secondary
antibodies were applied for 2 h in buffer containing serum, followed by
further washes. Secondary antibodies were as follows: FITC-labeled goat
anti–rabbit (Cappel Laboratories), TRITC-labeled goat anti–mouse IgG
 
1
 
,
TRITC-labeled donkey anti–rabbit (Jackson Laboratories), and FITC-
labeled donkey anti–sheep (Jackson Laboratories). Further washes in
blocking buffer minus serum were followed by several washes in PBS.
Sections were mounted in Vectashield (Vector Laboratories). Images
were captured with a Leica TCS4D confocal or Olympus BX60 micro-
scope, and figures were produced with Adobe Photoshop. 
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Immunoelectron Microscopy
 
Mice were perfused transcardially with heparinized (200 U heparin/100
ml) saline (0.89% NaCl) followed by freshly prepared 4% paraformalde-
hyde, 0.1% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4 for
2 h. The tissue was washed several times with 0.1 M sodium phosphate
buffer, pH 7.4, containing 3.5% sucrose and stained with 0.25% tannic
acid in the same buffer for 1 h at 4
 
8
 
C (subsequent steps were performed at
4
 
8
 
C). Aldehydes were quenched with 50 mM NH
 
4
 
Cl in 0.1 M sodium
phosphate buffer, pH 7.4. The tissue was washed four times in 0.1 M male-
ate buffer, pH 6.2, containing 4% sucrose, followed by 1% uranyl acetate
in the maleate sucrose buffer for 1 h. The tissue was dehydrated to 100%
ethanol (from 70% ethanol onward all steps were at 
 
2
 
20
 
8
 
C), infiltrated
with a 1:1 ratio of LR Gold (Agar Scientific Ltd.) and ethanol, followed by
a 7:3 ratio of LR Gold and ethanol, and two changes of LR Gold for 2–3 h
each. The tissue was infiltrated overnight in LR Gold containing 0.5%
benzoin methyl ether and embedded in gelatin capsules. Polymerization
was by UV irradiation at a wavelength of 365 nm for 24 h at 
 
2
 
20
 
8
 
C.
Sections on formvar carbon–coated nickel grids were blocked for 40
min at room temperature with 1% BSA, 0.5% fish skin gelatin, 0.05% Tri-
ton X-100, 0.05% Tween 20 in 10 mM Tris buffer, pH 7.4, containing 500
mM NaCl, and incubated with NFC1 antibody in the same buffer at 4
 
8
 
C
overnight. Grids were washed four times with the above buffer and incu-
bated for 1 h with goat anti–rabbit IgG conjugated to 10 nm gold (1:20
Avrion). The grids were washed on drops of distilled water, fixed with
2.5% aqueous glutaraldehyde, and rinsed in a stream of distilled water.
After postfixing for 15 min with 2% aqueous OsO
 
4
 
,
 
 
 
the grids were stained
with uranyl acetate and lead citrate and examined at 80 kV in a Phillips
Biotwin electron microscope.
 
In Situ Hybridization
 
RNA was prepared from adult mouse brains by TRIZOL extraction (Life
Technologies) for RT-PCR. Reverse transcription was performed with 1
 
m
 
g of RNA using SuperScript™II reverse transcriptase (400 U; Life Tech-
nologies) in the presence of random hexamers (Life Technologies). After
incubation at 42
 
8
 
C for 45 min, reactions were terminated by heating at
80
 
8
 
C. DNA in 1 
 
m
 
l of the first strand reaction was amplified by PCR with
Dynazyme (Flowgen). Primer sequences were selected from the published
neurofascin (ankyrin-binding protein) sequence (available from Gen-
Bank/EMBL/DDBJ under accession No. L11002) (Davis et al., 1996) that
would specifically amplify products from either the 155- or 186-kD splice
variants of neurofascin (see Fig. 1). A probe specific for NF155 was ampli-
fied from within the third FNIII domain of neurofascin with a forward
primer, 5
 
9
 
-CCTGAACAGCACAGCCATCAG-3
 
9
 
 (nucleotides 3,550–
3,570) and a reverse primer 5
 
9
 
-GACCACAACCATCTCCTGCTTG-3
 
9
 
(nucleotides 3,775–3,754). A probe specific for NF186 was amplified from
within the mucin domain of neurofascin using a forward primer, 5
 
9
 
-TGT-
GAGCAGTACTGATGCTAC-3
 
9
 
 (nucleotides 4,189–4,209) and a re-
verse primer, 5
 
9
 
-GTGATGACGGTACTGCTGAATG-3
 
9
 
 (nucleotides
4,635–4,615). The products were cloned into the pGEM-T vector
(Promega) and sequenced. The cDNA templates were linearized with ei-
ther NotI or NcoI and transcribed with either T7 (antisense probes) or
SP6 RNA (sense probes) polymerases (Boehringer Mannheim), respec-
tively. The cRNA probes were labeled with [
 
35
 
S]UTP and hybridized to
sections (5–10 
 
m
 
m) of fresh mouse tissue that had been frozen in isopen-
tane cooled to 
 
2
 
70
 
8
 
C on liquid nitrogen as described (Collinson et al.,
1998).
Figure 1. Domain structure of NF186 and NF155 showing the
mucin domain and the third fibronectin type III repeat unique to
the two respective isoforms (Davis et al., 1996).
Figure 2. Differential expres-
sion of NF186 and NF155
transcripts in mouse CNS.
Mouse parasagittal brain sec-
tions (A and B) retinas (C
and D), optic nerve, and
parasagittal sections of cere-
bellum at different postnatal
ages (F–H) were hybridized
with riboprobes specific for
NF186 (A and C) or NF155
(B and D–H) and viewed by
dark-field microscopy. NF186
signal was disseminated, but
clearly recognizable in cer-
tain neuronal populations
such as in the hippocam-
pus (h) and the cerebellar
Purkinje cell layer (A, pcl).
NF155 transcripts were con-
centrated in the oligodendro-
cyte- and myelin-rich corpus
callosum (cc) and cerebellar
white matter (wm) tracts (B).
Neurons in the retinal gan-
glion cell layer (gcl), inner
nuclear layer (inl), or outer
nuclear layer (onl) bodies
were rich in NF186 tran-
scripts (C) but were devoid of
NF155 mRNA (D). Note that
the retinal pigment epithelium layer (pe) appears as a bright line in dark-field microscopy (C–E). Robust expression of NF155 mRNA
in cells that were presumed to be oligodendrocytes was found in the optic nerve at P12 (E). NF155 mRNA levels declined from P8 at the
early stages of myelination to P24 (F–H) in the cerebellar white matter although expression persisted in these tracts at a low level (H). 
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Results
 
NF186 and NF155 Are Differentially Expressed in 
Neurons and Glia
 
Neurofascin has been characterized as a neuronal cell
adhesion molecule in the developing and mature CNS
(Rathjen et al., 1987a,b; Davis et al., 1996). However, we
also demonstrated strong expression of the gene by in situ
hybridization in oligodendrocytes (Collinson et al., 1998).
Furthermore, it appeared that in the myelinating optic
nerve, which does not contain neuronal mRNAs, the pri-
mary neurofascin transcript appeared to be NF155 rather
than NF186 (Collinson et al., 1998). To establish if these
two neurofascin isoforms were indeed expressed in a cell
type–specific fashion in the CNS, we prepared probes for
in situ hybridization and for immunocytochemistry that
recognized the mucin (NF186) or the third fibronectin
type III (NF155) domains (Fig. 1). In situ hybridization
analysis of postnatal day 21 (P21) mouse brain with iso-
form-specific riboprobes demonstrated that NF186 mRNA
was widely distributed with strong signals from certain neu-
ron populations such as the hippocampus and the Purkinje
cells of the cerebellum (Fig. 2 A). In contrast, NF155 mRNA
was strongly expressed in white matter tracts (Fig. 2 B).
The differential expression of the two neurofascin iso-
forms was seen most dramatically in the retina and optic
nerve. The neurons of the retina, including the ganglion
cells, which project their axons to the optic nerve, were de-
void of NF155 mRNA (Fig. 2 D), whereas each of the reti-
nal neuron layers displayed strong signals with the NF186
probe (Fig. 2 C). In contrast, cells in the optic nerve it-
self, which were presumed to be oligodendrocytes, were
strongly labeled with the NF155-specific riboprobe (Fig. 2
E). The use of a specific riboprobe confirmed the transient
nature of NF155 expression during the most active period
of myelination in the cerebellar white matter tracts that
had been observed earlier with a nonspecific neurofascin
probe (Fig. 2, F–H; Collinson et al., 1998). We found that,
Figure 3. (A) Characterization of neurofascin isoform-specific antibodies. Three rabbit antibodies were tested by Western blotting us-
ing mouse optic nerve homogenate. The first antibody (NFC1) was raised against a region at the extreme COOH terminus of the intra-
cellular domain common to both NF186 and NF155 (lane a), the second (MNF2) to a sequence within the mucin domain specific to
NF186 (lane b) and the third (NFF3) to the third FNIII domain specific to NF155 (lane c). (B) Immunolocalization of NF186 and NF155
to neurons and oligodendrocytes, respectively. Purkinje cell neurons of the cerebellum are strongly positive for NF186, particularly in
the plasma membrane (arrows) and initial axonal segment (arrowheads) (A, fluorescence; B, fluorescence with phase overlay). A stri-
atal oligodendrocyte is shown labeled with antibodies against NF155 (C) and MAG (D), an oligodendrocyte marker. The overlay (E)
shows that the two proteins colocalize to the oligodendrocyte cell body and the early wraps of myelin around the axon (arrow). In addi-
tion, punctate staining with the anti-NF155 antibody can be observed at sites that are presumed to be nascent paranodes (arrowheads,
and see Fig. 4). Bars, 10 mm. 
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in a similar fashion, the expression of NF155 transcripts in
the developing optic nerve also declined after a transient
peak of expression (data not shown). All sense riboprobe
controls yielded no discernible signal (data not shown).
To demonstrate that these cells were indeed oligoden-
drocytes, we generated neurofascin isoform–specific anti-
bodies (Fig. 3 A). In optic nerve extracts, neither of these
antibodies detected the minor 140-kD isoform of neuro-
fascin found in other regions of the brain (Davis et al.,
1996). NF186 protein was clearly neuronal, as demon-
strated by strong expression in the plasma membrane and
initial segments of the Purkinje cells of the cerebellum
(Fig. 3 B, A and B) as previously shown by Bennett and
co-workers (Davis et al., 1996). Double labeling for NF155
and an antibody against the oligodendrocyte marker
MAG demonstrated that, at early stages of myelination,
neurofascin was expressed in the cell bodies of oligoden-
drocytes (Fig. 3 B, C–E). Some punctate staining for
NF155 was also observed which probably represented na-
scent paranodal labeling (see below). The NF155 antibody
was shown to be specific for myelinating oligodendrocytes
because, at the onset of myelination, those cell bodies de-
tected by the NF155 antibody were always MAG-positive.
This excludes expression of NF155 by astrocytes or oligo-
dendrocyte precursors in the optic nerve.
 
NF155 Localizes to the Paranodal Axo-Glial Junction
 
In the myelinating optic nerve, NF155 is first observed at
the cell body of the oligodendrocyte and in a diffuse pat-
tern on the first processes of the myelin sheath as they en-
gage the axon (Fig. 4 A, A and B). A dramatic restriction
in the localization of the protein occurs over the next two
days: the protein is no longer detectable in oligodendro-
cyte cell bodies, but it is concentrated in puncta on nerve
fibers (Fig. 4 A, C and D). These foci of expression corre-
spond to paranodes since they flank the nodes of Ranvier,
at which ankyrin
 
G
 
 is concentrated in myelinated nerves
(Fig. 4 B, A–C; Kordeli et al., 1995). In contrast, NF186
colocalizes with ankyrin
 
G
 
, confirming its association with
the axonal membrane at the node of Ranvier (Davis et al.,
1996). Evidence that NF155 is a glial component of the
paranodal axo-glial junction was provided by immunoelec-
tron microscopy. In a longitudinal section (Fig. 5, A, A
 
9
 
, B,
and C) and in a tangential section (Fig. 5 D), the protein is
seen to be localized at the base of the cytoplasm-filled
paranodal loops, where they appose the axonal mem-
brane. Although tyrosine phosphorylation inhibits the
ankyrin-mediated association of neurofascin with the actin
cytoskeleton (Tuvia et al., 1997), restriction of NF155 to
paranodes in the optic nerve does not appear to require
complete dephosphorylation since NF155 is phosphory-
Figure 4. In the nodal re-
gion, NF155 is concentrated
at the paranodes of myeli-
nated fibers in the mouse op-
tic nerve, whereas NF186 is
restricted to the node of
Ranvier. (A) NF155 (green)
either alone (A and C) or
overlaid with NF-M neurofil-
ament staining (red, B and
D) displayed a dramatic re-
striction in localization be-
tween P10 and P12 in the
optic nerve. (B) Double la-
beling with an antibody that
recognizes both NF155 and
NF186 (A) or NF186 (D)
with an antibody that identi-
fies the node of Ranvier
marker ankyrinG (B and E)
demonstrates that NF155 is
localized to the paranodes,
whereas NF186 is at the node
itself (the respective overlays
are shown in C and F). Bars:
(C and D) 5 mm; (F) 1 mm. 
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lated at P12, a time when it has become restricted to the
axo-glial junction (Fig. 6). 
 
NF155 of Myelinating Glia Colocalizes with Neuronal 
Caspr1/Paranodin at Paranodes
 
Caspr1/paranodin is known to be an axonal constituent of
the paranodal axo-glial junction (Einheber et al., 1997; Me-
negoz et al., 1997; Peles et al., 1997a,b). Further substantia-
tion of the restriction of NF155 to the paranodal regions of
mouse optic nerve axons was provided by its colocalization
with Caspr1 (Fig. 7, A and B), which was also observed at
the paranodes formed by Schwann cells in mouse sciatic
nerve (Fig. 7, C–E). Additionally, in the sciatic nerve, both
antibodies decorated a helical ribbonlike structure (Fig. 7 E,
arrow), which probably represents the interface between
the inner mesaxon of the myelin sheath and the axon. In
situ hybridization of the mouse sciatic nerve with an NF155-
specific riboprobe demonstrated strong labeling of Schwann
cells indicating that, as in the CNS, NF155 was a product of
myelin-forming glial cells (Fig. 7 F). NF155 antibodies also
stained the cytoplasm-filled channels in the sheath, the
Schmidt-Lantermann incisures, where the protein colocal-
ized with MAG (Fig. 7 G), but the apposed axon was not
enriched in Caspr1 (data not shown). Immunostaining of
cocultures of myelinating rat Schwann cells and dissociated
DRG neurons (Fig. 7 H) revealed that the colocalized
NF155 and Caspr1 at the paranodes could be resolved into
a series of annuli, which probably reflects the lower density
of packing of the paranodal loops at the axo-glial junction
adhesion zone in this in vitro model of myelination by com-
parison with intact sciatic nerve fibers (Fig. 7, C and H).
 
NF155 Is Mislocalized in the Absence of Axo-Glial 
Junction Formation
 
The 
 
Shiverer 
 
(
 
Shi
 
) mouse lacks the major structural pro-
tein myelin basic protein (Roach et al., 1985). 
 
Shi 
 
oligo-
Figure 5. Immunoelectron microscopic detection
of NF155 at the paranodal axo-glial junction in
mouse optic nerve. (A–C) Immunogold labeling
of longitudinal sections of paranodes revealed
that the 10-nm gold particles were concentrated
at the base of the glial paranodal loops in the
axo-glial junction (arrowheads), a single gold
particle is observed at the node (arrow) which re-
flects labeling of NF186. A higher magnification
of the boxed area of A is shown in A9. (D) A tan-
gential section of a paranode shows strong label-
ing at the axon-glial interface. The axon (ax) is
indicated. Bars: (A) 200 nm; (A9, B, and C) 100
nm; (D) 200 nm. 
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dendrocytes extend processes around axons in the CNS,
but they are unable to produce compact myelin, neither do
they assemble paranodal axo-glial junctions (Inoue et al.,
1981; Rosenbluth, 1981). The absence of paranodes is re-
flected by the abnormal distribution of Caspr1 (Rasband
et al., 1999). Therefore, it was of interest to investigate
how this disruption might affect the localization of glial
neurofascin. In 
 
Shi 
 
mice, neurofascin displays an imma-
ture localization in that the protein is strongly expressed in
oligodendrocyte cell bodies (Fig. 8, G and J), and there is
no indication that it is targeted to discrete domains that
correspond to paranodes, as occurs in the nerves of wild-
type littermates where neurofascin and Caspr1 colocalize
(Fig. 8, A–F). In spite of their inability to establish a nor-
mal axo-glial junction, immunolabeling of 
 
Shi 
 
nerves
 
 
 
for
Caspr1 revealed that the protein was not distributed dif-
fusely along the axon, but instead was concentrated in dis-
crete patches (Fig. 8, G, J, and M) where it frequently
colocalized with NF155 (Fig. 8, I, L and O). This colocal-
ization suggested that Caspr1 and NF155 might still be ap-
posed in the glial and axonal plasma membranes, albeit at
an ectopic site. However, the fact that Caspr1 and contac-
tin did not coimmunoprecipitate with NF155 from the
brain using either neurofascin or Caspr1 antibodies sug-
gests that Caspr1 and NF155 do not interact directly (data
not shown).
 
Discussion
 
The sites of interaction between the terminal loops of
paranodal myelin and the axon are characterized by a nar-
row gap of 2.5–3 nm. These junctions represent highly
specialized zones that are likely to have a distinctive com-
Figure 6. Western blots of NF186
and NF155 immunoprecipitated
with the antibody NFC1 from
optic nerve homogenates at P10
and P12 probed successively with
antibodies to phosphotyrosine
and with NFC1, which identifies
both isoforms. NF155 is phos-
phorylated at P12 when it has lo-
calized to the axo-glial junction,
whereas NF186 was not phos-
phorylated at P12 when it is first
detectable in the optic nerve at
the node of Ranvier.
Figure 7. NF155 and Caspr1/paranodin colocalize at the axo-glial junction in the CNS and PNS. NF155 (in green) colocalization with
Caspr1 (in red) at the paranodes of mouse optic nerve is shown in a longitudinal section and in a transverse section (A and B, inset).
NF155 (green) and Caspr1 (red) also colocalize at the paranodes of teased adult mouse sciatic nerve fibers (C and D). Furthermore, the
overlay of the two images (E) reveals a helical ribbon stained by both antibodies, which extends from the paranodal region across the
internode in which both proteins are in register (E, arrow). Radioactive in situ hybridization visualized by dark-field microscopy con-
firmed that NF155 is expressed by Schwann cells in mouse sciatic nerve (F). MAG (red) and NF155 (green) are both constituents of
Schmidt-Lantermann incisures (G). A node and paranode in a Schwann cell–DRG neuron coculture are both stained with the NFC1
antibody (green) that recognizes both NF155 and NF186; in contrast, Caspr1 (in red) is restricted to the paranodes (H). Note the annular
appearance of the paranodal loops (arrow). Bars: (B, E, and G) 10 mm; (H), 2.5 mm. 
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plement of adhesion molecules. Furthermore, unlike the
tightly compacted lamellae found in the rest of the myelin
sheath, the paranodal myelin loops are filled with cyto-
plasm, which would facilitate the transduction of signals
from these transmembrane proteins to the cell body of the
myelin-forming glial cell. We have previously shown that
the cell adhesion molecule E-cadherin is strongly ex-
pressed in these paranodal loops (Fannon et al., 1995).
However, E-cadherin does not appear to be a component
of the axo-glial junction, but is rather a constituent of ad-
herens junctions at the proximal constrictions of the loops.
Another member of the immunoglobulin superfamily,
MAG, is also found in the paranodal loops in the PNS and
in periaxonal membranes but is not concentrated at the
junctional complex (Trapp et al., 1989a,b). Hence, the
NF155 isoform of neurofascin is the first glial cell adhesion
molecule of the axo-glial junction to be described.
What are the signals that initiate the development of
this regional specialization? The axonal transmembrane
proteins neurofascin and NrCAM, both members of the
L1 cell adhesion molecule family, have been proposed as
pioneer molecules in defining the site of node formation
(Lambert et al., 1997). We have confirmed previous work
that NF186 clusters at the node and is the axonal isoform
of neurofascin (Davis et al., 1996). Localization of this iso-
form to the node of Ranvier is coincident with the first ap-
pearance of ankyrin
 
G 
 
in the myelinating optic nerve (data
not shown). Hence, it is likely that these proteins play an
important role in assembling the molecular machinery re-
quired for generating the action potential typical of salta-
tory nerve impulse conduction at the node as suggested
previously by Bennett and co-workers (Davis et al., 1996;
Lambert et al., 1997).
It seems likely that physical interaction between the oli-
godendrocyte and the axon also plays an essential part in
defining the site of node assembly. The axo-glial adhesion
zone and the invertebrate septate junction both contain
members of the NCP (for neurexin IV, Caspr1/paranodin,
and Caspr2) subgroup of the neurexin superfamily (Mene-
goz et al., 1997; Peles et al., 1997a,b; Bellen et al., 1998; Po-
Figure 8. Compared with wild-type mice, NF155 (green) in the cerebellar white matter of Shiverer (Shi) mice is not targeted to para-
nodes but colocalizes with Caspr1 (red) at ectopic sites. At P16 in wild-type mice, NF155 (A and D) and Caspr1 (B and E) are localized
to paranodes where they colocalize (C and F). In contrast Shi oligodendrocytes retain high levels of NF155 (G and J) and do not target
the protein to paranodes. Nevertheless, NF155 and Caspr1 are frequently seen to colocalize on fibers at ectopic sites (H and I, K and L,
N and O, arrows) that do not have the normal morphological appearance of paranodes (F). Bars: (C, I, and L) 10 mm; (F and O) 5 mm. 
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liak et al., 1999). Neurexin IV is a constituent of the
pleated septate junctions of 
 
Drosophila
 
 that play an im-
portant role in mediating glial–glial interactions (Baum-
gartner et al., 1996), and Caspr1/paranodin has been
shown to be a constituent of paranodal junctions in both
the CNS and PNS (Einheber et al., 1997; Menegoz et al.,
1997). In the developing optic nerve, it appears that the
targeting of Caspr1 to prospective paranodes has a deter-
ministic role (Rasband et al., 1999). Indeed, without cor-
rect axon–glial contact, ankyrin
 
G
 
 fails to localize to the
node (Rasband et al., 1999). The clustering of sodium
channels occurs after the paranodes have been defined
and after ankyrin
 
G
 
 and NF186 have codistributed at the
node (Rasband et al., 1999; and this work). Hence, one
function of the paranodal junctions may be to prevent the
diffusion of sodium channels from the nodes, where they
are essential participants in the generation of the action
potential. The interaction between Caspr1, neurofascin,
and their respective ligands would play an important part
in ensuring this restricted distribution.
The integrity of the paranodal adhesive junction be-
tween axons and myelin-forming glia is not only vital for
the establishment of rapid rates of nerve impulse conduc-
tion during development, but it is also crucial for the main-
tenance of normal function in the mature nerve. Subtle de-
rangements in the interactions between the paranodal
loops of the myelin sheath and the axon represent the ear-
liest structural correlates of decreased rates of nerve im-
pulse conduction in myelinated fibers and may explain pa-
ralysis in some pathologically mild cases of demyelinating
disease (Griffin et al., 1996). In support of the importance
of the integrity of the axo-glial junction for normal func-
tion in myelinated fibers, a mouse mutant, which lacks
the enzyme UDP-galactose-ceramide galactosyltransferase
(CGT), and which is therefore unable to synthesize the
major myelin constituent galactocerebroside, assembles
compact myelin but has paranodal myelin loops that do
not make structurally normal connections with the axon
(Coetzee et al., 1996; Dupree et al., 1998, 1999). Conse-
quently, the conduction properties of the axons are se-
verely compromised, probably as a result of the aberrant
exposure of potassium channels in the juxtaparanodal do-
main of the axonal membrane to the perinodal ionic envi-
ronment. This conclusion is supported by the positive ef-
fect of the potassium channel blocker 4-aminopyridine on
the amplitude of nerve impulse conduction in the CNS fi-
bers of CGT mutant mice (Coetzee et al., 1996).
In the myelinating optic nerve, the initiation of axo-glial
adhesion assembly is a very early event, since paranodal
junctions have been detected as soon as the first spiral
of the oligodendrocyte process has ensheathed an axon
(Wiggins et al., 1988). Hence, the early targeting of NF155
to the paranodal myelin loops in the optic nerve probably
reflects the importance of this protein in the early estab-
lishment and stabilization of axon–glial contact. The
mechanism by which this targeting is achieved has yet to
be determined, but the COOH terminus of the neurofas-
cins does contain a functional ankyrin-binding site that is
regulated by tyrosine phosphorylation (Davis et al., 1993;
Davis and Bennett, 1994; Garver et al., 1997). Dephosphor-
ylation is required for ankyrin binding, which would sug-
gest that NF155 may only become fully competent to in-
 
teract with the actin cytoskeleton after it has reached its
paranodal destination, since phosphorylation of the pro-
tein in the optic nerve is still detectable after it has concen-
trated at the paranode. This would suggest that the actin
cytoskeleton is more likely to be important for neurofas-
cin’s function at the paranode rather than in ensuring de-
livery of this cell adhesion molecule to the axo-glial junc-
tion.
The axonal ligand for NF155 has yet to be identified. At
first sight, Caspr1 is a strong candidate, particularly in
view of the fact that both proteins not only colocalize at
normal paranodes, but they also codistribute at ectopic
sites in the nerves of 
 
Shi
 
 mutant mice that are unable to as-
semble paranodes (Rasband et al., 1999). Furthermore,
the two proteins codistribute in the PNS, where the inner
mesaxon of the myelin sheath apposes the axon. However,
these proteins do not colocalize at the Schmidt-Lanter-
mann incisures, which are cytoplasm-filled channels in the
compact peripheral myelin sheath, neither do they coim-
munoprecipitate from the brain. Hence, it seems likely that,
although members of a supramolecular adhesion complex,
they are unlikely to interact directly. The other elements
of the paranodal axo-glial junction remain to be identified.
In view of the importance of this unusual type of mamma-
lian adhesion complex for the cell biology of the neuron, it
will be of great interest to further establish its molecular
structure. The identification of the glial isoform of neuro-
fascin as a constituent of the junction is a step towards this
goal.
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